|
|
|
40
|
02335
|
SYMBICORT TURBU 320MCG | 9MCG INHR (AZN/COL) BUDESONIDE | FORMOTEROL
|
BUDESONIDE|FORMOTEROL
|
SYMBICORT TURBU
|
60 DOSES
|
A
|
52.19
|
52.19
|
INHALER
|
1
|
INHR
|
AZN
|
ASTRAZENECA AB
|
COL
|
COLLINS LTD
|
B
|
4892
|
RESPIRATORY AGENTS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
ORAL INHALATION
|
6
|
RESPIRATORY TRACT AGENTS
|
|
|
|
|
41
|
02335
|
SYMBICORT TURBU 320MCG|9MCG INHR (AZN) BUDESONIDE|FORMOTEROL
|
BUDESONIDE|FORMOTEROL
|
SYMBICORT TURBU
|
60 DOSES
|
A
|
52.19
|
52.1918
|
INHR
|
1
|
BOX
|
AZN
|
ASTRAZENECA AB
|
COL
|
COLLINS LTD
|
B
|
4892
|
RESPIRATORY AGENTS MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
ORAL INHALATION
|
6
|
RESPIRATORY AGENTS MISCELLANEOUS
|
|
|
|
|
40
|
0292J
|
CLINEX 150MG CAP (ARP/AHI) CLINDAMYCIN HCL
|
CLINDAMYCIN HYDROCHLORIDE
|
CLINEX
|
3X10
|
A
|
9.65
|
0.32
|
CAPSULE
|
28
|
CAP
|
ARP
|
ARISTOPHARMA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08122820
|
LINCOMYCINS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
41
|
0292J
|
CLINEX 150MG CAP (ARP) CLINDAMYCIN HCL (C)
|
CLINDAMYCIN HCL
|
CLINEX
|
3X10
|
C
|
10.28
|
0.3425
|
CAP
|
28
|
BOX
|
ARP
|
ARISTOPHARMA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08122820
|
LINCOMYCINS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
LINCOMYCINS
|
|
|
|
|
41
|
0292L
|
CLINDAMYCIN 150MG CAP (CAM)
|
CLINDAMYCIN HCL
|
CLINDAMYCIN
|
100'S
|
A
|
32.84
|
0.3284
|
CAP
|
28
|
BOX
|
CAM
|
MORNINGSIDE PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
08122820
|
LINCOMYCINS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
LINCOMYCINS
|
|
|
|
|
41
|
0292R
|
CLINDAVAN 150MG CAP (TPP) CLINDAMYCIN HCL
|
CLINDAMYCIN HCL
|
CLINDAVAN
|
10X10
|
A
|
25.2
|
0.252
|
CAP
|
28
|
BOX
|
TPP
|
THERDOSE PHARMA PRIVATE LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08122820
|
LINCOMYCINS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
LINCOMYCINS
|
|
|
|
|
40
|
0294K
|
CLINEX 300MG CAP (ARP/AHI) CLINDAMYCIN HCL
|
CLINDAMYCIN HYDROCHLORIDE
|
CLINEX
|
30'S
|
A
|
18.76
|
0.63
|
CAPSULE
|
28
|
CAP
|
ARP
|
ARISTOPHARMA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08122820
|
LINCOMYCINS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
41
|
0294K
|
CLINEX 300MG CAP (ARP) CLINDAMYCIN HCL (C)
|
CLINDAMYCIN HCL
|
CLINEX
|
30'S
|
C
|
18.76
|
0.6252
|
CAP
|
28
|
BOX
|
ARP
|
ARISTOPHARMA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08122820
|
LINCOMYCINS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
LINCOMYCINS
|
|
|
|
|
41
|
0294M
|
CLINDAMYCIN HCL 300MG CAP (KWA)
|
CLINDAMYCIN HCL
|
CLINDAMYCIN HCL
|
100'S
|
A
|
38.82
|
0.3882
|
CAP
|
28
|
BOX
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
08122820
|
LINCOMYCINS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
LINCOMYCINS
|
|
|
|
|
41
|
0294S
|
CLINDAVAN 300MG CAP (TPP) CLINDAMYCIN HCL
|
CLINDAMYCIN HCL
|
CLINDAVAN
|
10X10
|
A
|
47.38
|
0.4738
|
CAP
|
28
|
BOX
|
TPP
|
THERDOSE PHARMA PRIVATE LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
081228
|
ANTIBACTERIALS, MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
ANTIBACTERIALS, MISCELLANEOUS
|
|
|
|
|
40
|
0301Q
|
CLINDATECH 150MG/ML INJ (UBI/RXP) CLINDAMYCIN
|
CLINDAMYCIN PHOSPHATE
|
CLINDATECH
|
2ML AMP
|
BQ
|
6.12
|
6.12
|
INJECTION
|
0
|
AMP
|
UBI
|
UNITED BIOTECH (P) LIMITED
|
RXP
|
RX PRO INC
|
|
08122820
|
LINCOMYCINS
|
2022-04-01
|
2024-03-31
|
|
IV
|
6
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
41
|
0301S
|
CLINDAMYCIN PHOSPHATE 150MG/ML INJ (FSB) (B)
|
CLINDAMYCIN PHOSPHATE
|
CLINDAMYCIN PHOSPHATE
|
10X2ML
|
B
|
29.96
|
2.9956
|
AMP
|
112
|
BOX
|
FSB
|
FLAGSHIP BIOTECH
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
08122820
|
LINCOMYCINS
|
2024-04-01
|
2026-03-31
|
|
IV/IM
|
0
|
LINCOMYCINS
|
|
|
|
|
40
|
0302AA
|
LACLIDA 150MG/ML INJ (LDP/AHI) CLINDAMYCIN PH
|
CLINDAMYCIN PHOSPHATE
|
LACLIDA
|
10X4ML
|
BQ
|
79.86
|
7.99
|
INJECTION
|
0
|
AMP
|
LDP
|
LABDHI PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08122820
|
LINCOMYCINS
|
2022-04-01
|
2024-03-31
|
|
IV
|
6
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
41
|
0302AB
|
CLINDAMYCIN PHOSPHATE 150MG/ML INJ (FSB) (B)
|
CLINDAMYCIN PHOSPHATE
|
CLINDAMYCIN PHOSPHATE
|
10X4ML
|
B
|
51.7
|
5.1702
|
AMP
|
0
|
BOX
|
FSB
|
FLAGSHIP BIOTECH
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
08122820
|
LINCOMYCINS
|
2024-04-01
|
2026-03-31
|
|
IV/IM
|
0
|
LINCOMYCINS
|
|
|
|
|
40
|
0314B
|
FUSIDIC ACID DRESSING 1% (LDP/AHI)
|
FUSIDIC ACID
|
FUSIDIC ACID DRESSING
|
10'S
|
A
|
19.14
|
19.14
|
|
10
|
BOX
|
LDP
|
LABDHI PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
840404
|
ANTIBIOTICS TOPICAL
|
2022-04-01
|
2024-03-31
|
|
TOPICAL
|
0
|
SKIN-MUCOUS MEMBRANE PREPARATIONS
|
|
|
|
|
41
|
0314B
|
FUSIDIC ACID DRESSING 1% DRESSING (LDP)
|
FUSIDIC ACID
|
FUSIDIC ACID DRESSING
|
10'S
|
A
|
18.97
|
1.8974
|
EACH
|
10
|
BOX
|
LDP
|
LABDHI PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
840404
|
ANTIBIOTICS TOPICAL
|
2024-04-01
|
2026-03-31
|
|
TOPICAL
|
6
|
ANTIBIOTICS TOPICAL
|
|
|
|
|
40
|
0314L
|
BACTIGRAS 10CMX10CM (SMN/IMS) CHLORHEXIDINE
|
CHLORHEXIDINE
|
BACTIGRAS
|
10'S
|
A
|
29.00
|
2.90
|
|
10
|
EACH
|
SMN
|
SMITH & NEPHEW PHARMACEUTICALS
|
IMS
|
ISLANDS MEDICAL SUPPLIES INC
|
|
840492
|
ANTI-INFECTIVES TOPICAL MISCELLANEOUS
|
2022-04-06
|
2024-03-31
|
Add to Contract as Cat A
|
TOPICAL
|
6
|
SKIN-MUCOUS MEMBRANE PREPARATIONS
|
2022-04-06
|
|
|
|
41
|
0314L
|
BACTIGRAS 10CMX10CM (SMN) CHLORHEXIDINE
|
CHLORHEXIDINE
|
BACTIGRAS
|
10'S
|
A
|
31.75
|
3.175
|
EACH
|
10
|
BOX
|
SMN
|
SMITH & NEPHEW PHARMACEUTICALS
|
IMS
|
ISLANDS MEDICAL SUPPLIES INC
|
|
840492
|
ANTI-INFECTIVES TOPICAL MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
TOPICAL
|
0
|
ANTI-INFECTIVES TOPICAL MISCELLANEOUS
|
|
|
|
|
40
|
0321AB
|
GENTAMICIN 40MG/ML IV/IM INJ (RTM/PHA)
|
GENTAMICIN
|
GENTAMICIN
|
10X2ML
|
B
|
12.48
|
1.25
|
INJECTION
|
0
|
AMP
|
RTM
|
PANPHARMA GMBH
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
081202
|
AMINOGLYCOSIDES
|
2022-04-01
|
2022-05-31
|
|
IV/IM
|
6
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
40
|
0321AB
|
GENTAMICIN 40MG/ML IV/IM INJ (RTM/PHA)
|
GENTAMICIN
|
GENTAMICIN
|
10X2ML
|
B
|
19.27
|
1.93
|
INJECTION
|
0
|
AMP
|
RTM
|
PANPHARMA GMBH
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
081202
|
AMINOGLYCOSIDES
|
2022-06-01
|
2024-03-31
|
Price Change
|
IV/IM
|
6
|
ANTI-INFECTIVE AGENTS
|
2022-05-31
|
